Asian Pacific Journal of Cancer Prevention

  • 제16권10호
  • /
  • Pages.4323-4328
  • /
  • 2015
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Comparison between Radiological and Invasive Diagnostic Modalities in Diagnosis of Breast Cancer

  • Onur, Gulcin Ozkan (Karakavak Family Medicine Center) ;
  • Tarcan, Ercument (Izmir Katip Celebi University Ataturk Education and Research Hospital, General Surgery Clinic) ;
  • Onur, Asim (Department of General Surgery, Medical Faculty, Inonu University) ;
  • Can, Huseyin (Family Medicine Clinic, Izmir Katip Celebi University Ataturk Education and Research Hospital) ;
  • Atahan, Murat Kemal (Izmir Katip Celebi University Ataturk Education and Research Hospital, General Surgery Clinic) ;
  • Yigit, Seyran Ceri (Pathology Clinic, Izmir Katip Celebi University Ataturk Education and Research Hospital) ;
  • Cakalagaoglu, Fulya (Pathology Clinic, Izmir Katip Celebi University Ataturk Education and Research Hospital)
  • 발행 : 2015.06.03
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Breast cancer is the most common cause of deaths of cancer in women. Nowadays, following completion of imaging methods, mainly fine needle aspiration biopsy (FNAB) and core biopsy methods have been used for establishing cytopathological diagnosis although discussions regarding superiority continue. Materials and Methods: Those with a complaint of "mass in breast" along with those diagnosed to have a mass as a result of routine physical examination among all patients applying to our clinic between 01.01.2009 and 31.12.2011 were retrospectively assessed. Totals of 146 and 64 patients with complete radiological observation who had undergone FNAB and core biopsies, respectively, were evaluated. Postoperative pathological results of patients of both groups receiving surgery were also taken into consideration. All results were compared in terms of false positivity/negativity, sensitivity/specifity, surgery types and distribution of postoperative results with regard to diagnoses along with those of malignant/benign masses with regard to quadrants determined. Results: Diagnostic malignancy power of mammographic BIRADS classification was 87.3%. However, the value was 75% in the core biopsy group. Sensitivity and specifity following comparison of FNAB and postoperative pathology results of those receiving surgery were 85.4% and 92.9% while they were 93.5% and 100% in the core biopsy group. Diagnostic malignancy power, calculated by determining AUC in ROC analysis, of FNAB was 89.1% while that of core biopsy was 96.7%. Conclusions: It was shown that core biopsy is superior to FNAB in terms of sensitivity, specificity and accurate histopathological classification. However; quick, cheap and basic diagnosis by means of FNAB should not be ignored. Sensitivity of FNAB is rather high in experienced hands and furthermore it would be expected to be lower than with core biopsy.

키워드

참고문헌

  1. Abdel-Hadi M, Abdel-Hamid GF, Abdel-Razek N, Fawzy RK (2010). Should fine-needle aspiration cytology be the first choice diagnostic modality for assessment of all nonpalpable breast lesions? The experience of a breast cancer screening center in Alexandria, Egypt. Diagn Cytopathol, 38, 880-9. https://doi.org/10.1002/dc.21305
  2. Agacayak F, Ozturk A, Bozdogan A, et al (2014). Stereotactic vacuum-assisted core biopsy results for non-palpable Breast Lesions. Asian Pac J Cancer Prev, 15, 5171-4. https://doi.org/10.7314/APJCP.2014.15.13.5171
  3. Akcil M, Karaagaoglu E, Demirhan B (2008). Diagnostic accuracy of fine needle aspiration cytology of palpabl breast masses. An SROC curve with fixed and random effects linear meta-regression models. Diagn Cytopathol, 36, 303-10. https://doi.org/10.1002/dc.20809
  4. Aksaz E, oncel T, Atasoy G, et al (2005). Kor biyopsi acik biyopsilerin yerini alabilir mi? (Turkish) J Breast Health, 1, 18-21.
  5. Ariga R, Bloom K, Reddy VB, et al (2002). Fine-needle aspiration of clinically suspicious palpabl breast masses with histopathologic correlation. Am J Surg, 184, 410-3. https://doi.org/10.1016/S0002-9610(02)01014-0
  6. Barra A, Gobbi H, Rezende CA, et al (2008). Comparison of aspiration cytology and core needle biopsy according to tumor size of suspicious breast lesions. Diagn Cytopathol, 36, 26-31. https://doi.org/10.1002/dc.20748
  7. Boerner S, Fornage BD, Singletary E, et al (1999). Ultrasound guided fine-needle aspiration (FNA) of nonpalpabl breast lesions: a review of 1885 FNA cases using the National Cancer Institute-supported recommendations on the uniform approach to breast FNA. Cancer, 87, 19-24. https://doi.org/10.1002/(SICI)1097-0142(19990225)87:1<19::AID-CNCR4>3.0.CO;2-K
  8. Caruso ML, Gabrieli G, Marzullo G, et al (1998). Core biopsy as alternative to fine-needle aspiration biopsy in diagnosis of breast tumors. The Oncologist, 3, 45-9.
  9. Chaiwun B, Settakorn J, Ya-In C, et al (2002). Effectiveness of fine-needle aspiration cytology of breast: analysis of 2375 cases from Northern Thailand. Diagn Cytopathol, 26, 201-5. https://doi.org/10.1002/dc.10067
  10. Chaiwun B, Thorner P (2007). Fine needle aspiration for evalution of breast masses. Curr Opin Obstet Gynecol, 19, 48-55. https://doi.org/10.1097/GCO.0b013e328011f9ae
  11. Farshid G, Sullivan T, Jones T, et al (2014). Performance indices of needle biopsy procedures for the assessment of screen detected abnormalities in services accredited by breast screen Australia. Asian Pacific J Cancer Prev, 15, 10665-73.
  12. Frayne J, Sterrett GF, Harvery J et al (1996). Stereotactic 14-gauge core-biopsy of the breast: results from 101 patients. ANZ J Surg, 66, 585-91. https://doi.org/10.1111/j.1445-2197.1996.tb00824.x
  13. Gornstein B, Jacobs T, Bedard Y, et al (2004). Interobserver agreement of a probabilistic approach to reporting breast fine-needle aspirations on ThinPrep. Diagn Cytopathol, 30, 389-95. https://doi.org/10.1002/dc.20041
  14. Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  15. Ibrahim AE, Bateman AC, Theaker JM, et al (2001). The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions. J Clin Pathol, 54, 121-5. https://doi.org/10.1136/jcp.54.2.121
  16. Kumar (2009). Robbins and Cotran Pathologic Basis of Disease 8th edition, 1074-80.
  17. Shannon J, Douglas-Jones AG, Dallimore NS (2001). Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J Clin Pathol, 54, 762-5. https://doi.org/10.1136/jcp.54.10.762
  18. Leifland K, Lagerstedt U, Svane G (2003). Comparison of stereotactic fine needle aspiration cytology and core needle biopsy in 522 non-palpabl breast lesions. Acta Radiol, 44, 387-91. https://doi.org/10.1034/j.1600-0455.2003.00098.x
  19. Lieske B, Ravichandran D, Wright D (2006). Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma. Br J Cancer, 95, 62-6. https://doi.org/10.1038/sj.bjc.6603211
  20. Lifrange E, Kridelka F, Colin C (1997). Stereotaxic needle-core biopsy and fine-needle aspiration biopsy in the diagnosis of nonpalpable breast lesions: controversies and future prospects. Eur J Radiol, 24, 39-47. https://doi.org/10.1016/S0720-048X(96)01114-X
  21. Litherland JC, Evans AJ, Wilson AR, et al (1996). The impact of core-biopsy on preoperative diagnosis rate of screen detected breast cancers. Cli Radiol, 51, 562-5. https://doi.org/10.1016/S0009-9260(96)80136-X
  22. Michael S. P. Cheng, Fox J, Stewart A. Hart (2003). Impact of core biopsy on the management of screen-detected ductal carcinoma in situ of the breast. ANZ J Surg, 73, 404-6. https://doi.org/10.1046/j.1445-2197.2003.t01-1-02656.x
  23. Mueller-Holzner E, Fink V, Frede T, Marth C (2001). Immunohistochemical determination of Her2 expression in breast cancer from core biopsy specimens: A reliable predictor of Her2 status of the whole tumor. Breast Cancer Res Treat, 69, 13-9. https://doi.org/10.1023/A:1012281221647
  24. Nerurkar A, Osin P (2003). The role of new diagnostic techniques. Breast Cancer Res, 5, 305-8. https://doi.org/10.1186/bcr721
  25. Pisano ED, Fajardo LL, Tsimikas J, et al (1998). Rate of insufficient samples for fine needle aspiration for nonpalpabl breast lesions in a multicenter clinical trial: the Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigators. Cancer, 82, 679-88. https://doi.org/10.1002/(SICI)1097-0142(19980215)82:4<679::AID-CNCR10>3.0.CO;2-V
  26. Rosa M, Mohammadi A, Masood S (2012). The value of fine needle aspiration biopsy in the diagnosis and prognostic assesment of palpabl breast lesions. Diagn Cytopathol, 40, 26-34. https://doi.org/10.1002/dc.21497
  27. Shin H J C, Sniege N (1998). Is a diagnosis of infiltrating versus in situ ductal carcinoma of the breast possible in fine needle aspiration specimens? Cancer Cytopathol, 84, 186-91. https://doi.org/10.1002/(SICI)1097-0142(19980625)84:3<186::AID-CNCR11>3.0.CO;2-Q
  28. Shousha S (2003). Issues in the interpretation of breast core biopsies. Int J Surg Pathol, 11, 167-76. https://doi.org/10.1177/106689690301100303
  29. Tham T, Iyengar KR, Taib NA, Yip C (2009). Fine needle aspiration biopsy, core needle biopsy or excision biopsy to diagnose breast cancer-Which is the ideal method? Asian Pac J Cancer Prev, 10, 155-8.
  30. Willems SM, Van Deurzen SHM, Van Diest PJ (2012). Diagnosis of breast lesions: fine- needle aspiration cytology or core needle biopsy? A review. J Clin Pathol, 65, 287-92. https://doi.org/10.1136/jclinpath-2011-200410
  31. Zidan A, Christie BJ, Peston D, Shousa S (1997). Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. J Clin Pathol, 50, 59. https://doi.org/10.1136/jcp.50.1.59